drugset / Trial / NCT04212169
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.
Timeline
- Start
- 2019-12-09
- Primary completion
- 2022-07-21
- Completion
- 2022-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tozorakimab | Monoclonal antibody | — | — |